Correction to Lancet Diabetes Endocrinol 2018; 6: 17-26
- PMID: 29273167
- DOI: 10.1016/S2213-8587(17)30410-2
Correction to Lancet Diabetes Endocrinol 2018; 6: 17-26
Erratum for
-
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial.Lancet Diabetes Endocrinol. 2018 Jan;6(1):17-26. doi: 10.1016/S2213-8587(17)30326-1. Epub 2017 Oct 12. Lancet Diabetes Endocrinol. 2018. PMID: 29032078 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
